Federal Register / Vol. 62, No. 189 / Tuesday, September 30, 1997 / Notices 51111

Alabama, and thereby indirectly acquire

First American Bank, Decatur, Alabama.

2. Hibernia Corporation, New

Orleans, Louisiana; to merge with

Northwest Bancshares of Louisiana,

Inc., Mansfield, Louisiana, and thereby

indirectly acquire First National Bank in

Mansfield, Mansfield, Louisiana.

3. Riverside Gulf Coast Banking

Company, Cape Coral, Florida; to

become a bank holding company by

acquiring 100 percent of the voting

shares of Riverside Bank of the Gulf

Coast (in organization), Cape Coral,

Florida.

B. Federal Reserve Bank of Chicago

(Philip Jackson, Applications Officer)

230 South LaSalle Street, Chicago,

Illinois 60690-1413:

1. Fischer Bancorp, Inc., Fischer,

Illinois; to become a bank holding

company by acquiring 100 percent of

the voting shares of Fisher National

Bank, Fisher, Illinois.

C. Federal Reserve Bank of St. Louis

(Randall C. Sumner, Vice President) 411

Locust Street, St. Louis, Missouri 63102-

2034:

1. Security State Bancshares, Inc.,

Charleston, Missouri; to acquire 100

percent of the voting shares of

Merchants and Planters Bank of

Hornersville, Hornersville, Missouri.

Board of Governors of the Federal Reserve

System, September 25, 1997

William W. Wiles,

Secretary of the Board.

[FR Doc. 97–25935 Filed 9-29-97; 8:45 am]

BILLING CODE 6210-01-F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substances and

Disease Registry

[ATSDR–125]

Availability of the Final Child Health

Workgroup Report, Healthy Children—

Toxic Environments

AGENCY: Agency for Toxic Substances

and Disease Registry (ATSDR),

Department of Health and Human

Services (HHS).

ACTION: Notice.

SUMMARY: This notice announces the

availability of the final report, Healthy

Children-Toxic Environments, by the

ATSDR Board of Scientific Counselors’

Child Health Workgroup.

ADDRESSES: The report is accessible or

available through the following three

methods:

—The Internet at http://

atsdr1.atsdr.cdc.gov:8080/child/

chw497.html

—A request to the ATSDR Information

Center, Mailstop E57, 1600 Clifton

Rd., Atlanta, GA 30333, telephone

404–639–6357 or 1–800–447–1544

—A request via email to:

atsdric@cdc.gov

FOR FURTHER INFORMATION CONTACT: The

ATSDR Information Center, telephone

(404) 639–6357 or 1–800–447–1544.

SUPPLEMENTARY INFORMATION: In 1996,

the Agency for Toxic Substances and

Disease Registry (ATSDR), an operating

division of the U.S. Department of

Health and Human Services, launched a

Child Health Initiative. A Child Health

Workgroup was appointed by ATSDR’s

external Board of Scientific Counselors.

Members of the workgroup were

selected for their knowledge of

children’s environmental health. The

workgroup assessed ATSDR’s activities

as they pertain to individuals during

prenatal life, infancy, children, and

adolescence. The workgroup reviewed

the four divisions of ATSDR separately.

This effort included the review of

published goals and objectives for each

division, recent annual reports, and

many other publications from each

division. For each division, a meeting

was held between members of the

workgroup and the leadership of the

division.

The workgroup members determined

that, although key information gaps

could be identified, the most important

activity was to offer a critique of current

processes and suggestions for change

that would improve the quality of the

data, the pediatric impact of prevention,

and the future benefit of the ATSDR’s

activities for the children being served.

The availability of draft report for public

comment was announced in the Federal

Register on June 17, 1997 (62 FR 32812).

The availability of the final report

documenting this effort, Healthy

Children-Toxic Environments, is being

announced through this Federal

Register notice.

Dated: September 24, 1997.

Georgi Jones,

Director, Office of Policy and External Affairs,

Agency for Toxic Substances and Disease

Registry.

[FR Doc. 97–25836 Filed 9–29–97; 8:45 am]

BILLING CODE 4163–70–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee on Immunization

Practices: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Advisory Committee on

Immunization Practices (ACIP).

Times and Dates:

8:30 a.m.–4:45 p.m., October 22, 1997.

8:30 a.m.–1:15 p.m., October 23, 1997.

Place: CDC, Auditorium B, Building 2,

1600 Clifton Road, NE, Atlanta, Georgia

30333.

Status: Open to the public, limited only by

the space available.

Purpose: The Committee is charged with

advising the Director, CDC, on the

appropriate uses of immunizing agents. In

addition, under 42 U.S.C. § 1396s, the

Committee is mandated to establish and

periodically review and, as appropriate,

revise the list of vaccines for administration

to vaccine-eligible children through the

Vaccines for Children (VFC) program, along

with schedules regarding the Page 2

appropriate periodicity, dosage, and

contraindications applicable to the vaccines.

Matters to be Discussed: Under the

authority of 42 U.S.C. § 1396s, the Committee

will consider revision of the ACIP VFC

program resolution for Adolescent Hepatitis

B immunization.

Other topics include: updates on the

National Vaccine Program, the Vaccine

Injury Compensation Program, and the

influenza pandemic preparedness plan;

discussions on rabies postexposure

prophylaxis, the recommendations on

the use of Rotashield (Rotavirus

vaccine) as part of the routine childhood

immunization schedule, ACIP

guidelines on combination vaccines, the

harmonized immunization schedule,

public health laboratory capacity for

vaccine-preventable disease

surveillance, immunization of bone

marrow transplant (BMT) recipients, the

report from work group on algorithms

for immunization registries, and the

isolation of influenza type A(H5N1) in

Hong Kong. There will also be

presentations on the efficacy of live

attenuated influenza vaccine and the

Swedish acellular pertussis mass

vaccination project. Other matters of

relevance among the Committee’s

objectives may be discussed.

Agenda items are subject to change as

priorities dictate.

CONTACT PERSON FOR MORE INFORMATION:

Gloria A. Kovach, Committee